LGM
Logos Global Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.7M | Hold |
2,000,000
| – | – | 2.95% | 7 |
|
|
2025
Q1 | $20.4M | Buy |
+2,000,000
| New | +$20.4M | 3.62% | 8 |
|
|
2021
Q4 | – | Sell |
-15,000
| Closed | -$593K | – | 71 |
|
|
2021
Q3 | $593K | Buy |
+15,000
| New | +$593K | 0.04% | 54 |
|
|
2021
Q1 | – | Sell |
-450,000
| Closed | -$31.7M | – | 64 |
|
|
2020
Q4 | $31.7M | Sell |
450,000
-1,150,000
| -72% | -$81.1M | 2.72% | 8 |
|
|
2020
Q3 | $61.7M | Buy |
1,600,000
+1,200,000
| +300% | +$46.3M | 7.9% | 2 |
|
|
2020
Q2 | $15M | Buy |
+400,000
| New | +$15M | 3% | 14 |
|